Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]
Accurate dosing of the BPC-157 TB-500 blend requires a calibrated insulin syringe typically U-100 (1mL)
As the flowchart shows, testing is the starting line
The syringe visuals above will update in real-time.
Drug interactions have not been systematically evaluated
US$ 26.23
US$ 23.38
US$ 23.99
US$ 29.61
US$ 25.59
US$ 27.50
